WF
TAK icon

WealthTrust Fairport’s Takeda Pharmaceutical TAK Stock Holding History

WealthTrust Fairport’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1K Buy
+30
New +$604 ﹤0.01% 429

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WealthTrust Fairport's TAK Position: Q1 2019 in Review

WealthTrust Fairport opened a new position in Takeda Pharmaceutical (TAK) in Q1 2019: 30 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings.

390 funds tracked by Wall St. Rank hold TAK as of Q1 2019.

  • WealthTrust Fairport held 30 shares of Takeda Pharmaceutical worth $1K as of Q1 2019.
  • Takeda Pharmaceutical was a new WealthTrust Fairport position in Q1 2019.
  • Takeda Pharmaceutical made up ﹤0.01% of WealthTrust Fairport's portfolio in Q1 2019, its #429 holding.
  • 390 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.